CordovaCann Corp. (CSE:CDVA)
0.0350
+0.0050 (16.67%)
Jan 2, 2026, 1:36 PM EST
CordovaCann Revenue
CordovaCann had revenue of 3.66M CAD in the quarter ending September 30, 2025, a decrease of -0.98%. This brings the company's revenue in the last twelve months to 14.21M, up 1.60% year-over-year. In the fiscal year ending June 30, 2025, CordovaCann had annual revenue of 14.25M with 3.28% growth.
Revenue (ttm)
14.21M
Revenue Growth
+1.60%
P/S Ratio
0.26
Revenue / Employee
n/a
Employees
n/a
Market Cap
3.76M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 14.25M | 451.96K | 3.28% |
| Jun 30, 2024 | 13.80M | 202.44K | 1.49% |
| Jun 30, 2023 | 13.59M | 68.62K | 0.51% |
| Jun 30, 2022 | 13.53M | 3.21M | 31.08% |
| Jun 30, 2021 | 10.32M | 10.15M | 6,087.36% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| TILT Holdings | 128.37M |
| 4Front Ventures | 102.14M |
| Ayurcann Holdings | 31.28M |
| 1933 Industries | 17.42M |
| CanadaBis Capital | 15.08M |
| RAMM Pharma | 3.78M |
| Aion Therapeutic | 1.47M |
| Digital Commodities | 97.96K |